https://www.barrons.com/articles/sage-therapeutics-fda-depression-drug-d84f6bcf
0
0
Sage Stock Sinks After FDA Decision on Depression Drug - Barron's
8/7/23 at 2:04pm
Organization
Barron's
Authors
Josh Nathan-Kazis Emily Dattilo
Details
34 words
Summarize
Pharmaceuticals & Biotech Sage Stock Sinks FDA resource allocation cash runway pipeline prioritization Depression Drug - Barron workforce reorganization
Sage Therapeutics says it is 'evaluating resource allocation, including pipeline prioritization and a workforce reorganization with a goal of extending our cash runway.'
Create an account or login to join the discussion